Warning: The NCBI web site requires JavaScript to function. more...
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis.
Gould D, Yousaf N, Fatah R, Subang MC, Chernajovsky Y.
Arthritis Res Ther. 2007;9(1):R7.
Related citations
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid.
Gould DJ, Bright C, Chernajovsky Y.
Arthritis Res Ther. 2004;6(2):R103-13. Epub 2003 Dec 22.
A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications.
Gould DJ, Berenstein M, Dreja H, Ledda F, Podhajcer OL, Chernajovsky Y.
Gene Ther. 2000 Dec;7(24):2061-70.
Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants.
Bloquel C, Bessis N, Boissier MC, Scherman D, Bigey P.
Hum Gene Ther. 2004 Feb;15(2):189-201.
Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
Kim JM, Ho SH, Hahn W, Jeong JG, Park EJ, Lee HJ, Yu SS, Lee CS, Lee YW, Kim S.
Gene Ther. 2003 Aug;10(15):1216-24.
Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis.
Perez N, Plence P, Millet V, Greuet D, Minot C, Noel D, Danos O, Jorgensen C, Apparailly F.
Hum Gene Ther. 2002 Dec 10;13(18):2161-72.
TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH.
Ann Rheum Dis. 2003 Aug;62(8):707-14.
Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis.
Khoury M, Adriaansen J, Vervoordeldonk MJ, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D, Tak PP, Jorgensen C, Apparailly F.
J Gene Med. 2007 Jul;9(7):596-604.
Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis.
Grimstein C, Choi YK, Satoh M, Lu Y, Wang X, Campbell-Thompson M, Song S.
J Gene Med. 2010 Jan;12(1):35-44.
A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.
Arntz OJ, Geurts J, Veenbergen S, Bennink MB, van den Brand BT, Abdollahi-Roodsaz S, van den Berg WB, van de Loo FA.
Arthritis Res Ther. 2010;12(2):R61. Epub 2010 Apr 6.
Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P, Yang SY, Wu B, Song Z, Myers LK, Robbins PD, Wooley PH.
Ann Rheum Dis. 2005 Nov;64(11):1550-6. Epub 2005 Apr 28.
Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic mice.
Bloquel C, Denys A, Boissier MC, Apparailly F, Bigey P, Scherman D, Bessis N.
J Gene Med. 2007 Nov;9(11):986-93.
Effects of viral interleukin 10 introduced by in vivo electroporation on arthrogen-induced arthritis in mice.
Kuroda T, Maruyama H, Shimotori M, Higuchi N, Kameda S, Tahara H, Miyazaki J, Gejyo F.
J Rheumatol. 2006 Mar;33(3):455-62.
Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis.
Bessis N, Cottard V, Saidenberg-Kermanach N, Lemeiter D, Fournier C, Boissier MC.
J Gene Med. 2002 May-Jun;4(3):300-7.
CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis.
Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD.
J Clin Invest. 2003 Nov;112(9):1332-41.
Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.
Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM.
Mol Ther. 2002 Dec;6(6):727-36.
Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor.
Mageed RA, Adams G, Woodrow D, Podhajcer OL, Chernajovsky Y.
Gene Ther. 1998 Dec;5(12):1584-92.
Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.
Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H, Ylä-Herttuala S.
Gene Ther. 2003 Mar;10(6):459-66.
Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer.
Kim KN, Watanabe S, Ma Y, Thornton S, Giannini EH, Hirsch R.
J Immunol. 2000 Feb 1;164(3):1576-81.
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on